Tactile Systems Technology Inc (TCMD) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Tactile Systems Technology Inc   (NASDAQ: TCMD)


Tactile Systems Technology Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tactile Systems Technology Inc's ROI in the third quarter of 2026?
Tactile Systems Technology Inc achieved a return on average invested assets (ROI) of 9.61 % in its third quarter of 2026, this is above TCMD's average return on investment of 3.78%.
Tactile Systems Technology Inc invested over the 12 months ending in its third quarter of 2026 $248 million

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 107 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1038 to 1044.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -1.25 % -0.15 % 2.76 % 8.16 % 11.03 %
Y / Y Net Income Change TTM 31.09 % 64.52 % 70.61 % 28.34 % 252.43 %
Investment (TTM) in Millions 244 255 257 236 244
Return On Investment (TTM) 9.61 % 10.03 % 8.18 % 7.64 % 7.24 %
TCMD's Overall Ranking # 1044 # 1038 # 710 # 887 #
Seq. Investment Change TTM -0.05 % -0.04 % -0.65 % -0.51 % 1.06 %
Seq. Net Income Change TTM -4.22 % 22.51 % 6.34 % 5.05 % 20.21 %
Net Income (TTM) in Millions 24 25 20 19 18




Return On Investment TCMD's Ranking
Within: No.
Industry # 34
Sector # 108
Overall # 1044

Return On Investment Statistics
High Average Low
13.16 %
3.78 %
-14.55 %
(Jun 30 2024)   (Sep 30 2022)







Financial Statements
Tactile Systems Technology Inc's III. Quarter Investments $ 244 Millions TCMD's Balance sheet
Tactile Systems Technology Inc's III. Quarter Income $ 7 Millions Quarterly TCMD's Income Statement
TCMD's Income by Division See TCMD's Income by Division


TCMD Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 220 241 222 191 210
Y / Y Investment Growth -8.72 % 8.7 % 16.41 % -9.12 % 63.93 %
Net Income in Millions 19 17 29 -18 -12
Y / Y Net Income Growth 12.54 % -40.52 % - - -
Annual Return On Investment 8.67 % 7.03 % 12.85 % -9.37 % -5.63 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 8.67 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TCMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TCMD's Competitors
Subscribers only: Roi for Tactile Systems Technology Inc's Suppliers
Subscribers only: Return On Investment for TCMD's Customers

Other Ratios
TCMD's Roa TCMD's Inventory Turnover Ratio TCMD's Growth Rates TCMD's Dividend Statistics
TCMD's Profitability Ratios TCMD's Asset Turnover Ratio TCMD's Dividend Growth
TCMD's Roe TCMD's Valuation Ratios TCMD's Financial Strength Ratios TCMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %


Date modified: 2026-11-03T10:04:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.